CJC-1295 and GHK-Cu

Mentioned together

Named together in the same review articles, never tested together. This page says that plainly and shows why researchers list them side by side.

How the two mechanisms relate

Neutral. CJC-1295, a GHRH analogue, and GHK-Cu, a copper peptide studied for skin remodeling, are named together in research reviews but act on unrelated pathways, with no combined data recorded here.

This reading describes mechanism and is editorial. The grade above is the published record.

The compounds

CJC-1295

A long-acting GHRH analogue studied for growth-hormone release. Two early human trials measured hormone levels; no human study here reports a functional outcome.

Full profile, dosing and safety →

GHK-Cu

A naturally occurring copper peptide studied mostly for skin remodeling and wound healing. Its strongest human result is an older randomized ulcer study.

Full profile, dosing and safety →

Check these in the interaction tool →